Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| pectin {pectin} - Faecalibacterium |
📓
Modulation of Pectin on Mucosal Innate Immune Function in Pigs Mediated by Gut Microbiota. Microorganisms (Microorganisms ) Vol: 8 Issue 4 Pages: Pub: 2020 Apr 8 Epub: 2020 Apr 8 Authors Wu W , Zhang L , Xia B , Tang S , Xie J , Zhang H , Html Article Publication |
| pectin {pectin} - Faecalibacterium |
👪
Prebiotic potential of pectin and pectic oligosaccharides to promote anti-inflammatory commensal bacteria in the human colon. FEMS microbiology ecology (FEMS Microbiol Ecol ) Vol: 93 Issue 11 Pages: Pub: 2017 Nov 1 Epub: Authors Chung WSF , Meijerink M , Zeuner B , Holck J , Louis P , Meyer AS , Wells JM , Flint HJ , Duncan SH , Publication |
| pectin {pectin} - Faecalibacterium |
📓
Contribution of acetate to butyrate formation by human faecal bacteria. The British journal of nutrition (Br J Nutr ) Vol: 91 Issue 6 Pages: 915-23 Pub: 2004 Jun Epub: Authors Duncan SH , Holtrop G , Lobley GE , Calder AG , Stewart CS , Flint HJ , Publication Publication |
| pectin {pectin} - Faecalibacterium |
📓
The role of short-chain fatty acids in microbiota-gut-brain communication. Nature reviews. Gastroenterology & hepatology (Nat Rev Gastroenterol Hepatol ) Vol: 16 Issue 8 Pages: 461-478 Pub: 2019 Aug Epub: Authors Dalile B , Van Oudenhove L , Vervliet B , Verbeke K , Publication Publication |
| pectin {pectin} - Faecalibacterium |
👶
Anti-diabetic effect of modified 'Guanximiyou' pummelo peel pectin on type 2 diabetic mice via gut microbiota. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 242 Issue Pt 2 Pages: 124865 Pub: 2023 Jul 1 Epub: 2023 May 17 Authors Zang Y , Du C , Ru X , Cao Y , Zuo F , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
